Sign in Subscribe
Legislative bills

House Committee on Appropriations Increases Funding for Breast Cancer Programs Amidst Fiscal Year 2026 Bill Advancement

Strategic Insights

— 2 min read

The House Committee on Appropriations has taken a significant step towards improving breast cancer research and detection by increasing funding for critical programs. As part of the fiscal year 2026 (FY26) bill advancement, the committee has allocated $206.4 million for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a $5.5 million increase from the previous year. This program has provided essential services to millions of women without adequate health insurance, diagnosing nearly 90,000 invasive breast cancers and over 25,000 premalignant breast lesions since 1991.

Additionally, the National Institutes of Health (NIH) will receive $46.9 billion, a $99 million increase from FY25, with $7.3 billion allocated for the National Cancer Institute (NCI), a $48 million increase. Susan G. Komen, a leading breast cancer organization, has expressed gratitude for these investments but also urged the committee to reconsider significant cuts to other critical programs under HHS, including the Centers for Disease Control and Prevention (CDC), ARPA-H, and AHRQ.

Key Takeaways:

  • The House Committee on Appropriations has increased funding for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) by $5.5 million, totaling $206.4 million for fiscal year 2026.
  • The National Institutes of Health (NIH) will receive $46.9 billion, a $99 million increase from FY25, with $7.3 billion allocated for the National Cancer Institute (NCI), a $48 million increase.
  • Susan G. Komen has applauded the committee's support for NBCCEDP and NCI but expressed disappointment over significant cuts to other critical programs under HHS, including the CDC, ARPA-H, and AHRQ.
  • The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) has provided access to breast health services for over 6.5 million women since 1991, diagnosing nearly 90,000 invasive breast cancers and over 25,000 premalignant breast lesions.
  • Susan G. Komen has been actively advocating for decades to maximize funding for these programs and will continue to do so as the House and Senate proceed with FY26 negotiations.
  • The collective power of breast cancer advocates has been instrumental in securing these investments, according to Susan G. Komen.

Statistics:

  • $206.4 million allocated for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal year 2026, a $5.5 million increase from FY25.
  • $46.9 billion allocated for the National Institutes of Health (NIH) for fiscal year 2026, a $99 million increase from FY25.
  • $7.3 billion allocated for the National Cancer Institute (NCI) for fiscal year 2026, a $48 million increase from FY25.
  • Over 6.5 million women have received access to breast health services through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) since 1991.
  • Nearly 90,000 invasive breast cancers and over 25,000 premalignant breast lesions have been diagnosed through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) since 1991.

Sources:

  • Susan G. Komen - "Susan G. Komen Urges Passage of FY26 Appropriations Bill

September 10"

Read more